{"id":"https://openalex.org/W2007262203","doi":"https://doi.org/10.1097/jom.0b013e3180459ff2","title":"An Employer-Based Cost-Benefit Analysis of a Novel Pharmacotherapy Agent for Smoking Cessation","display_name":"An Employer-Based Cost-Benefit Analysis of a Novel Pharmacotherapy Agent for Smoking Cessation","alternate_titles":[],"publication_year":2007,"publication_date":"2007-04-01","ids":{"openalex":"https://openalex.org/W2007262203","doi":"https://doi.org/10.1097/jom.0b013e3180459ff2","mag":"2007262203","pmid":"https://pubmed.ncbi.nlm.nih.gov/17426529"},"language":"en","primary_location":{"id":"doi:10.1097/jom.0b013e3180459ff2","doi":"https://doi.org/10.1097/jom.0b013e3180459ff2","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jom.0b013e3180459ff2","pdf_url":null,"source":{"id":"https://openalex.org/S156862075","display_name":"Journal of Occupational and Environmental Medicine","issn_l":"1076-2752","issn":["1076-2752","1536-5948"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Occupational &amp; Environmental Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2007262203"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060388851","display_name":"Kenneth C. Jackson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Jackson","raw_affiliation_strings":["Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, Salt Lake City, UT 84108, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, Salt Lake City, UT 84108, USA","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074021789","display_name":"Robert Nahoopii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Nahoopii","raw_affiliation_strings":["From the Pharmacotherapy Outcomes Research Center (Dr Jackson, Dr Nahoopii, Dr Said, Dr Brixner), the University of Utah College of Pharmacy, Salt Lake City, UT","University of Utah,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pharmacotherapy Outcomes Research Center (Dr Jackson, Dr Nahoopii, Dr Said, Dr Brixner), the University of Utah College of Pharmacy, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165"]},{"raw_affiliation_string":"University of Utah,","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112263180","display_name":"Qayyim Said","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qayyim Said","raw_affiliation_strings":["From the Pharmacotherapy Outcomes Research Center (Dr Jackson, Dr Nahoopii, Dr Said, Dr Brixner), the University of Utah College of Pharmacy, Salt Lake City, UT","University of Utah,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pharmacotherapy Outcomes Research Center (Dr Jackson, Dr Nahoopii, Dr Said, Dr Brixner), the University of Utah College of Pharmacy, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165"]},{"raw_affiliation_string":"University of Utah,","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110085967","display_name":"Riad D Dirani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Riad Dirani","raw_affiliation_strings":["From the Pharmacotherapy Outcomes Research Center (Dr Jackson, Dr Nahoopii, Dr Said, Dr Brixner), the University of Utah College of Pharmacy, Salt Lake City, UT","Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pharmacotherapy Outcomes Research Center (Dr Jackson, Dr Nahoopii, Dr Said, Dr Brixner), the University of Utah College of Pharmacy, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165"]},{"raw_affiliation_string":"Pfizer","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040963321","display_name":"Diana I Brixner","orcid":"https://orcid.org/0000-0001-6637-6359","observed_orcids":["https://orcid.org/0000-0001-6637-6359"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Diana Brixner","raw_affiliation_strings":["From the Pharmacotherapy Outcomes Research Center (Dr Jackson, Dr Nahoopii, Dr Said, Dr Brixner), the University of Utah College of Pharmacy, Salt Lake City, UT","PHARMACOTHERAPY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pharmacotherapy Outcomes Research Center (Dr Jackson, Dr Nahoopii, Dr Said, Dr Brixner), the University of Utah College of Pharmacy, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165"]},{"raw_affiliation_string":"PHARMACOTHERAPY","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5040963321"],"corresponding_institution_ids":["https://openalex.org/I223532165"],"apc_list":null,"apc_paid":null,"fwci":4.8617,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.94376353,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":97},"biblio":{"volume":"49","issue":"4","first_page":"453","last_page":"460"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/varenicline","display_name":"varenicline","score":0.8679999709129333},{"id":"https://openalex.org/keywords/bupropion","display_name":"bupropion","score":0.9909999966621399},{"id":"https://openalex.org/keywords/smoking-cessation","display_name":"smoking cessation","score":0.9760000109672546},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.6919999718666077},{"id":"https://openalex.org/keywords/cost-benefit-analysis","display_name":"cost-benefit analysis","score":0.7590000033378601},{"id":"https://openalex.org/keywords/quit-rates","display_name":"quit rates","score":0.6579999923706055},{"id":"https://openalex.org/keywords/workplace-smoking","display_name":"workplace smoking","score":0.5019999742507935},{"id":"https://openalex.org/keywords/decision-tree","display_name":"decision tree","score":0.6349999904632568},{"id":"https://openalex.org/keywords/sensitivity-analysis","display_name":"sensitivity analysis","score":0.48399999737739563}],"concepts":[{"id":"https://openalex.org/C2777053506","wikidata":"https://www.wikidata.org/wiki/Q411330","display_name":"Varenicline","level":3,"score":0.9933440685272217},{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.9639259576797485},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.7914879322052002},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6711574196815491},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6694777011871338},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.42504042387008667},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.22715544700622559},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.09705105423927307},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000041","descriptor_name":"Absenteeism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068580","descriptor_name":"Varenicline","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D003663","descriptor_name":"Decision Trees","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006264","descriptor_name":"Health Benefit Plans, Employee","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008283","descriptor_name":"Maintenance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011810","descriptor_name":"Quinoxalines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015397","descriptor_name":"Program Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016540","descriptor_name":"Smoking Cessation","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D016540","descriptor_name":"Smoking Cessation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017046","descriptor_name":"Cost Savings","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D017049","descriptor_name":"Employer Health Costs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/jom.0b013e3180459ff2","doi":"https://doi.org/10.1097/jom.0b013e3180459ff2","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jom.0b013e3180459ff2","pdf_url":null,"source":{"id":"https://openalex.org/S156862075","display_name":"Journal of Occupational and Environmental Medicine","issn_l":"1076-2752","issn":["1076-2752","1536-5948"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Occupational &amp; Environmental Medicine","raw_type":"journal-article"},{"id":"pmid:17426529","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17426529","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of occupational and environmental medicine","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8560000061988831},{"display_name":"Decent work and economic growth","id":"https://metadata.un.org/sdg/8","score":0.7257999777793884}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W136657926","https://openalex.org/W1576807410","https://openalex.org/W1976515753","https://openalex.org/W1993112595","https://openalex.org/W1998637589","https://openalex.org/W2037405140","https://openalex.org/W2078723422","https://openalex.org/W2107200746","https://openalex.org/W2135798157","https://openalex.org/W2136768101","https://openalex.org/W2143588078","https://openalex.org/W2164074287","https://openalex.org/W2164386461","https://openalex.org/W2170345251","https://openalex.org/W2407381503","https://openalex.org/W2412396363","https://openalex.org/W2463861392","https://openalex.org/W2916741317","https://openalex.org/W4249431887","https://openalex.org/W6601782271","https://openalex.org/W6605562474"],"related_works":["https://openalex.org/W81998782","https://openalex.org/W2131082605","https://openalex.org/W2002880485","https://openalex.org/W2131509743","https://openalex.org/W2087289747","https://openalex.org/W1898829324","https://openalex.org/W2088910893","https://openalex.org/W1977689964","https://openalex.org/W2059391699","https://openalex.org/W2071678117"],"abstract_inverted_index":{"INTRODUCTION:":[0],"An":[1],"employer-based":[2],"cost-benefit":[3],"analysis":[4],"for":[5,68,71,76,82],"varenicline":[6,51,103,122],"versus":[7],"bupropion":[8,72,77,114],"was":[9,24,85],"conducted":[10,43],"using":[11],"clinical":[12],"outcomes":[13],"from":[14],"a":[15,35],"recently":[16],"published":[17],"trial.":[18],"METHODS:":[19],"A":[20],"decision":[21],"tree":[22],"model":[23],"developed":[25],"based":[26,44],"on":[27,45],"the":[28,53,128],"net":[29],"benefit":[30,112,120],"of":[31,55,95,121,132],"treatment":[32],"to":[33,106,109],"produce":[34],"nonsmoker":[36],"at":[37],"1":[38],"year.":[39],"Sensitivity":[40],"analyses":[41],"were":[42,66],"quit":[46,93,100],"rates":[47,94],"with":[48,102],"placebo":[49],"and":[50,52,80],"cost":[54,61,87,111,131],"varenicline.":[56,133],"RESULTS:":[57],"Estimated":[58],"12-month":[59],"employer":[60],"savings":[62],"per":[63],"non-smoking":[64],"employee":[65],"$540.60":[67],"varenicline,":[69],"$269.80":[70],"SR":[73,78,115],"generic,":[74],"$150.80":[75],"brand,":[79],"$81.80":[81],"placebo.":[83],"Varenicline":[84],"more":[86],"beneficial":[88],"than":[89],"placebo,":[90],"which":[91],"had":[92],"16.9%":[96],"or":[97],"less.":[98],"The":[99,118],"rate":[101],"would":[104],"have":[105],"be":[107],"<or=16.9%":[108],"lose":[110],"over":[113,125],"generic.":[116],"CONCLUSIONS:":[117],"economic":[119],"is":[123],"improved":[124],"bupropion,":[126],"despite":[127],"increased":[129],"initial":[130]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2007262203","counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
